Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

Jean-Michel Dogné; Julien Hanson; Xavier de Leval; Philippe Kolh; Vincent Tchana-Sato; Laurence de Leval; Stéphanie Rolin; Alexandre Ghuysen; Patrick Segers; Bernard Lambermont; Bernard Masereel; Bernard Pirotte

doi:10.1124/jpet.103.063610

Research ArticleCARDIOVASCULAR

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A₂ Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

Jean-Michel Dogné, Julien Hanson, Xavier de Leval, Philippe Kolh, Vincent Tchana-Sato, Laurence de Leval, Stéphanie Rolin, Alexandre Ghuysen, Patrick Segers, Bernard Lambermont, Bernard Masereel and Bernard Pirotte

Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 498-505; DOI: https://doi.org/10.1124/jpet.103.063610

Jean-Michel Dogné

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julien Hanson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xavier de Leval

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philippe Kolh

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vincent Tchana-Sato

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Laurence de Leval

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stéphanie Rolin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexandre Ghuysen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patrick Segers

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernard Lambermont

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernard Masereel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernard Pirotte

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 309, Issue 2

1 May 2004

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Ble…

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleCARDIOVASCULAR

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A₂ Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 498-505; DOI: https://doi.org/10.1124/jpet.103.063610

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleCARDIOVASCULAR

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A₂ Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 498-505; DOI: https://doi.org/10.1124/jpet.103.063610

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A₂ Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

Plain text

Vertical Tabs

Jump to comment:

In this issue

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A₂ Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

Citation Manager Formats

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A₂ Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals